Interim Report of BB BIOTECH AG as of June 30, 2010 – MarketWatch

By admin

Interim Report of BB BIOTECH AG as of June 30, 2010
MarketWatch
Valuation of biotechnology companies at historic lows In its Interim Report, BB BIOTECH looked back on a difficult first half-year period for 2010.

and more »



categoriaBiotechnology commentoComments Off | dataJuly 29th, 2010

About...

This author published 8885 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research